Ayalla is essentially a disruptive company, founded in 1973, with a firm and established purpose of becoming a benchmark in innovation, quality, and excellence in technologies and products. With over 50 uninterrupted years in the Brazilian market, Ayalla has a strong presence in the Pharmaceutical, Nutraceutical, and Human and Animal Health and Nutrition industries. Our business encompasses a significant diversity of Solutions in new business models, from Concept through innovative products (APIs, FDFs, and ingredients), to Technology through cutting-edge technology platforms. Ayalla has built a unique history by strategically establishing a global and reliable network of suppliers to serve the life sciences market. Another important factor in our success is the recruitment and maintenance of a highly qualified and experienced team, which provides, among other things, robust scientific, technical, and regulatory support. We have been fulfilling our initial purpose for five decades, which is to constantly seek trends and technological solutions for innovation, integrated logistics, and a reliable supply chain, to better serve our customers.
Alvaro Rodrigues, 269
Cordeiro Village - Sao Paulo - SP








Releases: PUREHMB (human and animal), VERISPERSE (technology), PLEXOZOME (technology),
Products: MOBILEE (human and animal), DERMIAL (human and animal), HYDROCURC (human and animal), LEVAGEN/LEVAGEN+ (human and animal), COLLAVANT N2 (human and animal), MAXFOL (human and animal), MEDITEANOX (human and animal), MENAQUINGOLD (human and animal), HU58 (human), NEM (human and animal), ESC (human), NATAXTIN (human), AHIFLOWER (human and animal), TESTOFEN (human), LIBIFEM (human), ARROW LACTASE (human and animal), BIOPS (human and animal), LIPISPERSE (TECHNOLOGY), AQUACELLE (TECHNOLOGY), METHYLCOBALAMIN (human)
Other product suggestions: DAO (human), PINUS PINASTER (human)